Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Manon C Stam-Slob"'
Autor:
Manon C. Stam-Slob, Sef J.L.W. van den Beuken, René van der Griend, Lenneke E.M. Haas, Jeroen P.H.M. van den Wijngaard, Serena Slavenburg, Sanjay U.C. Sankatsing
Publikováno v:
Clinical Infection in Practice, Vol 15, Iss , Pp 100153- (2022)
Background: A parasitic Strongyloides stercoralis infection is a common disease in endemic (sub)tropical areas. It may persist for years due to auto-infection. Most patients have no or mild respiratory, cutaneous, and gastrointestinal symptoms. Case
Externí odkaz:
https://doaj.org/article/078a56fe5ceb4c7f8ce68d2ffc4202aa
Autor:
Tamar I. de Vries, Manon C. Stam‐Slob, Ron J. G. Peters, Yolanda van der Graaf, Jan Westerink, Frank L. J. Visseren
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 1 (2022)
Background For translating an overall trial result into an individual patient’s expected absolute treatment effect, differences in relative treatment effect between patients need to be taken into account. The aim of this study was to evaluate wheth
Externí odkaz:
https://doaj.org/article/97929b56dda744a7ac050e784c95a8fb
Autor:
Myrthe J. van Dijk, Brigitte A. van Oirschot, Manon C. Stam‐Slob, Esmé Waanders, Bert van der Zwaag, Eduard J. van Beers, Judith J. M. Jans, Peter Willem van der Linden, Jose M. Torregrosa Diaz, Betty Gardie, François Girodon, Rik Schots, Noortje Thielen, Richard van Wijk
Publikováno v:
British Journal of Haematology. 200:249-255
Erythrocytosis is associated with increased red blood cell mass and can be either congenital or acquired. Congenital secondary causes are rare and include germline variants increasing haemoglobin (Hb)-oxygen affinity (e.g., Hb or bisphosphoglycerate
Autor:
Manon C. Stam‐Slob, Yolanda van der Graaf, Jacoba P. Greving, Jannick A.N. Dorresteijn, Frank L.J. Visseren
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 2 (2017)
BackgroundA validated prediction model estimates the absolute benefit of intensive versus standard lipid‐lowering therapy (LLT) with statins on next major cardiovascular events for individual patients with coronary artery disease. We aimed to asses
Externí odkaz:
https://doaj.org/article/fbb33fd68be64b34a70ece2de1298e1d
Autor:
Jannick A N Dorresteijn, Marco Alings, Yolanda van der Graaf, Ron J.G. Peters, John W. Eikelboom, Manon C. Stam-Slob, Stuart J. Connolly, Frank L.J. Visseren, Joep van der Leeuw
Publikováno v:
Circulation, 139(25), 2846. Lippincott Williams and Wilkins
Background: We aimed to estimate absolute benefit and harm from treatment with dabigatran in individual patients with atrial fibrillation, and to select the optimal dose for each individual. Methods: We derived and validated a prediction model for is
Autor:
Manon C, Stam-Slob, Stuart J, Connolly, Yolanda, van der Graaf, Joep, van der Leeuw, Jannick A N, Dorresteijn, John W, Eikelboom, Ron J G, Peters, Marco, Alings, Frank L J, Visseren
Publikováno v:
Circulation. 139(25):2846-2856
BACKGROUND: We aimed to estimate absolute benefit and harm from treatment with dabigatran in individual patients with atrial fibrillation, and to select the optimal dose for each individual. METHODS: We derived and validated a prediction model for is
Autor:
Maarten J. Cramer, Frank L.J. Visseren, Suzanne E Engelen, Yolanda van der Graaf, Gert J. de Borst, Manon C. Stam-Slob, Jan Westerink, L. Jaap Kappelle, Diederick E. Grobbee
Publikováno v:
International Journal of Cardiology, 248, 301. Elsevier Ireland Ltd
Objective Diabetes mellitus is associated with an increased risk for cardiovascular morbidity and mortality. The vascular burden in terms of incidence of cardiovascular events (CVE) and vascular interventions is however poorly quantified. In this stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::445c6a40cbd9634bf95d4bff48be41dd
https://dspace.library.uu.nl/handle/1874/357660
https://dspace.library.uu.nl/handle/1874/357660
Autor:
Geert J. M. G. van der Heijden, Wouter P. Kluijfhout, Medard F M van den Broek, Nina M. Kaper, Corien Gudden, Mark C. J. Aarts, Manon C. Stam-Slob
Publikováno v:
Otolaryngology-Head and Neck Surgery, 150(4), 533-537. Mosby Inc.
van den Broek, M F M, Gudden, C, Kluijfhout, W P, Stam-Slob, M C, Aarts, M C J, Kaper, N M & van der Heijden, G J M G 2014, ' No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base ', Otolaryngology-Head and Neck Surgery, vol. 150, no. 4, pp. 533-537 . https://doi.org/10.1177/0194599814522595
van den Broek, M F M, Gudden, C, Kluijfhout, W P, Stam-Slob, M C, Aarts, M C J, Kaper, N M & van der Heijden, G J M G 2014, ' No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base ', Otolaryngology-Head and Neck Surgery, vol. 150, no. 4, pp. 533-537 . https://doi.org/10.1177/0194599814522595
OBJECTIVE:To evaluate the diagnostic value of symptom duration and purulent rhinorrhea in adults suspected of having acute bacterial rhinosinusitis.DATA SOURCES:PubMed, EMBASE, and the Cochrane Library.REVIEW METHODS:We performed a comprehensive syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::425550f5e9b05728af399401cc6c4421
https://dare.uva.nl/personal/pure/en/publications/no-evidence-for-distinguishing-bacterial-from-viral-acute-rhinosinusitis-using-symptom-duration-and-purulent-rhinorrhea-a-systematic-review-of-the-evidence-base(22d09173-b923-42c8-a03e-4e2d8f699c7c).html
https://dare.uva.nl/personal/pure/en/publications/no-evidence-for-distinguishing-bacterial-from-viral-acute-rhinosinusitis-using-symptom-duration-and-purulent-rhinorrhea-a-systematic-review-of-the-evidence-base(22d09173-b923-42c8-a03e-4e2d8f699c7c).html
Publikováno v:
BMJ (Clinical research ed.). 351
The bottom line For women with a history of venous thromboembolism, we recommend: A 28 year old woman, recently diagnosed as having a first deep venous thrombosis (DVT), visits her general practitioner. She has no predisposing factors (such as surger
Autor:
Anton J. M. de Craen, Peter W. Macfarlane, Yolanda van der Graaf, Manon C. Stam-Slob, Frank L.J. Visseren, Ajay Gupta, Naveed Sattar, J. Wouter Jukema, Stella Trompet, Patricia M. Kearney, Neil R Poulter
Publikováno v:
Clinical Research in Cardiology, 106(1), 58. D. Steinkopff-Verlag
Clinical Research in Cardiology, 106(1), 58-68
Clinical Research in Cardiology
Clinical Research in Cardiology, 106(1), 58-68
Clinical Research in Cardiology
Objective To estimate the absolute treatment effect of statin therapy on major adverse cardiovascular events (MACE; myocardial infarction, stroke and vascular death) for the individual patient aged ≥70 years. Methods Prediction models for MACE were